Press Release | Tue Oct 1, 2013 10:00am EDT

Data from Merck’s Investigational Hepatitis C Treatment Portfolio to be Presented at the 64th American Association for the Study of Liver Diseases Annual Meeting

* Reuters is not responsible for the content in this press release.